Symptom Management Summary Tenesmus

Symptom Management Summary Tenesmus

Guideline Summary for Health Professionals Tenesmus Effective Date: January 1, 2019 Last Updated: February 7, 2019 Tenesmus Management Tips for Healthcare Professionals Guiding Principles: Rectal tenesmus is a distressing symptom in patients with advanced cancer and challenging to treat. Step 1. Top underlying treatable causes and diagnosis: • Definition: Tenesmus can be defined as the persistent and usually painful sensation of rectal fullness/incomplete evacuation. Tenesmus results in a sensation of needing to defecate multiple times a day, adversely impacting on quality of life. Often due to an infiltrating cancer, tenesmus can be accompanied by painful smooth muscle cramping or neuropathic pain. • Can be mistaken as diarrhea or constipation • Rule out non-malignant causes e.g. inflammatory bowel disease, treatment side effects (e.g. radiation proctitis), constipation Step 2a. Non-pharmacological management: • Treat underlying malignancy when possible; may include radiotherapy (but usually not immediately effective for symptom control) • Optimize dietary interventions to minimize diarrhea and/or constipation Step 2b. Pharmacological options (limited evidence): • Optimize analgesics including opioids • Belladonna and Opium suppositories (65 mg – 15 mg) rectal, daily-bid prn (Max: 4 doses/day; contraindicated in severe renal impairment) o If Belladonna and Opium suppositories are unavailable locally, compounding pharmacies can provide an alternative suppository: 7.5 mg morphine and 15 mg belladonna • Buscopan 10 mg q6h po prn (Caution: increased side effects in elderly) • Consider hydrocortisone (e.g. radiation proctitis) or lidocaine 2% gel rectal enema • Limited evidence supporting use of adjuvants such as calcium channel blockers (Caution: associated cardiovascular toxicities) o Nifedipine 5 mg po bid-tid (can titrate up to 20 mg bid-tid) o Diltiazem 30 mg po q6h (if effective, can be transitioned to Diltiazem ER 120 mg po daily) Step 3. When to refer to other specialists: • Ongoing difficult to control pain despite above treatment • Oncology: To ensure maximal oncologic treatment of local disease • Palliative: If concomitant other symptoms and/or moderate to high opioid doses • Anesthetic/Pain Service: For interventional and/or injections and/or neuraxial analgesia • Spinal surgery: Lumbar Sympathectomy • GI: Endoscopic Laser Therapy (ELT) [potential for serious complications] Page 1 of 2 Guideline Summary for Health Professionals Tenesmus Effective Date: January 1, 2019 Last Updated: February 7, 2019 NOTE: Guidelines do not replace individualized care and clinical expertise. References: 1. Laoire A, Fettes L et Murtagh F EM, A systematic review of the effectiveness of palliative interventions to treat rectal tenesmus, Palliative Medicine, 2017 31(10): 975-81. 2. Radiation Oncology Management Decisions ed. 2, Philadelphia, USA, ed. KS Clifford Chao, Lippincott Williams and Wilkins, 2002. p. 720-1. 3. The Pallium Palliative Pocketbook: a peer-reviewed, referenced resource. 2nd Cdn ed. Ottawa, Canada: Pallium Canada; 2016. Vision: Improving quality of life for Albertans with advanced cancer. Page 2 of 2 .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us